Loraz-img-01.jpg (Loraz Img 01)
Lorazepam Injection
Product Images NDC 65219-368
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 65219-368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Loraz-img-02.jpg (Loraz Img 02)
Loraz-label-01.jpg (Loraz Label 01)
This is a description for a medication called Lorazepam. It is an injection containing 2 mg/mL of the active ingredient. The medication is intended for intramuscular use and needs to be diluted for intravenous use. It should be stored in a refrigerator away from light and any unused portion should be discarded. The medication comes in a 1 mL single-dose vial under the brand PREMIERProRx®. It is a prescription medication with NDC 65219-368-14.*
Loraz-label-02.jpg (Loraz Label 02)
This is a description of an injectable medication with the NDC 65219-368-24. It contains lorazepam 2 mg/mL and is intended for intramuscular and intravenous use after dilution. It comes in 25 single-dose vials, each containing 1 mL of the solution. The medication should be refrigerated and any unused portion should be discarded. The solution contains polyethylene glycol 400, propylene glycol, and benzyl alcohol as a preservative. The usual dosage should be followed as per the insert. The medication should not be used if it is discolored or contains a precipitate. It needs to be protected from light and stored in the carton.*
Loraz-struc-01.jpg (Loraz Struc 01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
